London – The incidence of rare blood clot is higher following a Covid-19 infection than two doses of AstraZeneca or Pfizer/BioNTech vaccines, according to a new study. Sir Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, in a statement, said: “This real-world study offers further evidence of the favourable benefit:risk profile of Vaxzeria and demonstrates the critical role all Covid-19 vaccines …
London – AstraZeneca’s intranasal Covid vaccination reduced virus concentrations and curbed transmission in two different SARS-CoV-2 animal models, showing need for further investigation as a potential method of inoculating Covid-19 shots. The trial, led by researchers including from the US National Institutes of Health (NIH) and the University of Oxford, UK, was published in the journal Science Translational Medicine. Vincent …
New York – Teleconferencing platforms like Zoom and Microsoft Teams helped people stay connected during the coronavirus pandemic. But the platforms could not capture sounds accurately enough for clinicians to successfully treat and evaluate patients with voice and speech disorders, according to a study. Hasini Weerathunge, a graduate student at BU’s Rafik B Hariri Institute for Computing and Computational Science …
Singapore – A team of researchers has found a combination of antiviral and anti-inflammatory drugs that can be used to treat Covid-19 patients with moderate effects. The combination could strongly inhibit the SARS-CoV-2 virus in laboratory tests, making it suitable for further clinical evaluation, Professor Dean Ho, director of the NUS’s Institute for Digital Medicine, has said: “We are looking …
Brussels – Pfizer raised the price of its Covid-19 vaccine by over a quarter and Moderna by more than a tenth in the latest EU supply contracts as Europe battled supply disruptions and concerns about side effects from rival products. The new price for a Pfizer shot was €19.50 against €15.50 previously, according to portions of the contracts seen by …
Beijing – An inhaled version of CanSino Biologics’ (CanSinoBio) Covid-19 vaccine triggered immune responses without serious side effects, an early-stage clinical trial showed. The two-dose candidate requires lower dosages than the injected version and could help CanSinoBio boost its production capacity, the company’s chief executive said in April. Two inhaled doses of the Ad5-nCoV vaccine, given 28 days apart, elicited …
London – The incidence of rare blood clot is higher following a Covid-19 infection than two doses of AstraZeneca or Pfizer/BioNTech vaccines, according to a new study. “This real-world study offers further evidence of the favourable benefit:risk profile of Vaxzeria and demonstrates the critical role all Covid-19 vaccines are playing in combating the pandemic,” said Sir Mene Pangalos, Executive Vice …
MOSCOW (Reuters) – Russia has given the green light for clinical trials combining a British shot from AstraZeneca Plc (AZN.L) and Oxford University with Russia’s Sputnik V vaccine to go ahead, according to Russia’s state drug register. The health ministry’s ethical committee had in May suspended the approval process for the clinical trials, and requested additional information. According to the …
Washington – The Cambridge, Massachusetts-based company Moderna has said that it plans to expand the size of its COVID-19 vaccine study in younger children to better understand rare side effects, such as a type of heart inflammation recently flagged by US health authorities. Moderna is talking to the US Food and Drug Administration to enroll more study participants under age …
USA – The safety and well-being of the people who use our products is our number one priority. Rare cases of the neurological disorder, Guillain-Barré syndrome have been reported following vaccination with the Janssen COVID-19 vaccine. Most occurred within 42 days after vaccination. While the chance of having this occur is very low, Johnson & Johnson has updated its COVID-19 …
